Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease

Quinn, Lori, Playle, Rebecca, Drew, Cheney J.G., Taiyari, Katie, Williams-Thomas, Rhys, Muratori, Lisa M., Hamana, Katy, Griffin, Beth Ann, Kelson, Mark, Schubert, Robin, Friel, Ciaran, Morgan-Jones, Philippa, Rosser, Anne and Busse, Monica 2022. Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease. Parkinsonism & Related Disorders 101 , pp. 75-89. 10.1016/j.parkreldis.2022.06.013

[thumbnail of Quinn et al 2022.pdf]
Preview
PDF - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (2MB) | Preview

Abstract

Introduction While physical activity (PA) is recognized as important in Huntington's disease (HD) disease management, there has been no long-term evaluation undertaken. We aimed to evaluate the feasibility of a nested (within cohort) randomized controlled trial (RCT) of a physical therapist-led PA intervention. Methods Participants were recruited from six HD specialist centers participating in the Enroll-HD cohort study in Germany, Spain and U.S. Assessments were completed at baseline and 12 months and linked to Enroll-HD cohort data. Participants at three sites (cohort) received no contact between baseline and 12 month assessments. Participants at three additional sites (RCT) were randomized to PA intervention or control group. The intervention consisted of 18 sessions delivered over 12 months; control group participants received no intervention, however both groups completed monthly exercise/falls diaries and 6-month assessments. Results 274 participants were screened, 204 met inclusion criteria and 116 were enrolled (59 in cohort; 57 in RCT). Retention rates at 12-months were 84.7% (cohort) and 79.0% (RCT). Data completeness at baseline ranged from 42.3 to 100% and at 12-months 19.2–85.2%. In the RCT, there was 80.5% adherence, high intervention fidelity, and similar adverse events between groups. There were differences in fitness, walking endurance and self-reported PA at 12 months favoring the intervention group, with data completeness >60%. Participants in the cohort had motor and functional decline at rates comparable to previous studies. Conclusion Predefined progression criteria indicating feasibility were met. PACE-HD lays the groundwork for a future, fully-powered within cohort trial, but approaches to ensure data completeness must be considered.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Engineering
Medicine
Centre for Trials Research (CNTRR)
Publisher: Elsevier
ISSN: 1353-8020
Funders: Jacques and Gloria Gossweiler Foundation
Date of First Compliant Deposit: 24 June 2022
Date of Acceptance: 19 June 2022
Last Modified: 11 Jul 2022 16:13
URI: https://orca.cardiff.ac.uk/id/eprint/150763

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics